Akebia Therapeutics | AKBA - 债务



金融业
股票价格
USD
资产
USD 349.66M
现金及等价物
USD 155.55M
销售成本
USD 10.34M
流动资产
USD 229.55M
流动负债
USD 160.87M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 25.02M
销售毛利
USD 47.28M
债务利息支出
349.66M
贷款资金
USD 24.75M
市值
USD 192.3M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13.02M
贸易债权人
USD 9.42M
应收帐款人
USD 47.03M


债务 更改 日
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amgen USD 57.32B 2.72B 2026-03
Ardelyx USD 208.26M 653K 2026-03
Astellas Pharma JPY 565.95B 265.47B 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Bayer EUR 36.45B 2.93B 2025-12
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Celltrion KRW 160.58B 733.3M 2026-03
Cspc Pharmaceutical CNY 641.11M 146.11M 2025-12
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Exelixis USD 165.93M 3.61M 2026-06
Fresenius Medical Care EUR 10.96B 66.06M 2026-06
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 54.99B 7.05B 2026-03
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Moderna USD 1.3B 7M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 8.2M 554K 2026-03
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 45.84M 1.7M 2026-06
Prothena USD 7.65M 1.43M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Qiagen NV USD 1.65B 165.82M 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Zealand Pharma A/S 414M 8.23M 2026-03
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03